Quantcast

Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
July 23, 2014, 01:19:41 AM

Login with username, password and session length


Members
Stats
  • Total Posts: 631519
  • Total Topics: 47804
  • Online Today: 244
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: WELLNESS: A Major Victory Against HIV  (Read 1650 times)

0 Members and 1 Guest are viewing this topic.

Offline ichigo_kun

  • Member
  • Posts: 49
WELLNESS: A Major Victory Against HIV
« on: March 27, 2012, 11:27:27 AM »
A group of scientists recently discovered a major vulnerability of HIV strains: the antibody PGT 128.

HIV (Human Immunodeficiency Virus) is a virus that prevents the immune system from working properly. This condition cripples the body from defending against infections that are life-threatening.

For decades, scientists have been improving vaccines that allow people with HIV to live longer. But no vaccine could prevent all HIV infections because HIV mutates quickly. The recent discovery of the antibody PGT 128 is groundbreaking due to its unprecedented effectiveness on a broad range of HIV strains.

An antibody PGT 128 attaches to an HIV strain and penetrates its glycan shield. Glycan shields are what normally protect the strain from the body’s immune system, but the antibody PGT 128 binds to the strains and reaches through the glycan shield. Finally, it neutralizes the strain by passing through the shield and grabbing the protein called GP120.

Scientists predict that PGT 128 is effective against HIV strains precisely because most of them have glycan shields. How broad are its effects? Researchers from the United States, United Kingdom, Japan and the Netherlands tested blood of HIV-positive volunteers and concluded that PGT 128 is effective against 70% of HIV strains.

Although the antibody does not provide a solution to all HIV infected people around the world, scientists are optimistic about finding a potential lifetime cure because of the success of this research. "We'll probably need multiple targets on the virus for a successful vaccine, but certainly PGT 128 shows us a very good target," said Dennis Burton, a Professor at The Scripps Research Institute and scientific director of the International AIDS Vaccine Initiative’s (IAVI) Neutralizing Antibody Center, in a press release.

Perhaps the most exciting fact is not that PGT 128 can neutralize about 70 percent of the world’s HIV strains. It’s the finding that most HIV strains, despite their unpredictable mutations, share common structures that can make them vulnerable to certain antibodies, providing hope that we can fight the virus more effectively.

Junsuk Ahn is a freshman in the College of Human Ecology. She may be reached at jahn@cornellsun.com. The Missing Link: Health, Nutrition and Wellness appears on Tuesdays. 
http://cornellsun.com/blog/content/2012/03/27/wellness-major-victory-against-hiv
 

Offline Dr.Strangelove

  • Member
  • Posts: 206
Re: WELLNESS: A Major Victory Against HIV
« Reply #1 on: March 27, 2012, 09:42:12 PM »
This is exciting research, though not exactly new. The article just references to some publication from last October (the original paper is here: http://www.sciencemag.org/content/334/6059/1097.short)
ScienceDaily has a more detailed general article about this antibody: http://www.sciencedaily.com/releases/2011/10/111013141816.htm

They've been searching for those kind of antibodies for so many years. The part that I don't understand is, if they already have a number of antibodies that seem to work pretty well, why are there no large scale clinical tries using those?
Using antibodies is a much easier and cheaper way that let's say the complicaed ex-vivo zinc-finger-nuclease approach that Sangamo is taking.
And because those effective antibodies have been extracted from humans (and not engineered), they should not have unexpected side effects, right?
Can anyone enlighten me as of why there isn't more progress in applying those kind of antibodies towards a (therapeutic or immunizing) vaccine? Thanks.

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.